Abstract
Antiphospholipid syndrome (APS) or the presence of antiphospholipid antibodies (aPL), usually presents as pregnancy loss. However, aPL have also been reported to affect implantation, placentation, and early embryonic development. The binding of aPl to β2GP1 may lead to breakdown of the phospholipid adhesion molecules between different elements of trophoblast. As aPL affect placental growth and function, aPl may prevent implantation presenting as infertility. Lupus anticoagulant and anticardiolipin antibody have been implicated in the prothrombotic effects of APS. Antibodies to other phospholipids such as anti-phosphatidylserine, phosphatidyl ethanolamine, phosphatidyl choline, phosphatidyl glycerol, phosphatidyl Inositol etc. may be more relevant in infertility. Their role remains to be clarified. There is theoretical evidence from animal models and clinical infertility practice that aPL has a role in infertility. However, a large-scale meta-analysis has failed to confirm the association. To determine whether infertility or even pregnancy loss is associated with aPL, it is necessary to know that the embryo is chromosomally normal. Pregestational diagnosis has shown that up to 60% of embryos may be chromosomally aneuploid in failed in vitro fertilization (IVF); hence, may confound our understanding concerning the association between aPL and infertility, failed IVF or even pregnancy loss.
Similar content being viewed by others
References
Ruiz-Irastorza G, Khamashta MA, Hughes GRV (2002) Treatment of pregnancy loss in Hughes syndrome: a critical update. Autoimmun Rev 1:298–304
Lockshin MD (1992) Antiphospholipid antibody syndrome. JAMA 268:1451–1453
Stone S, Khamashta MA, Poston L (2001) Placentation, antiphospholipid syndrome and pregnancy outcome. Lupus 10:67–74
Shurtz-Swirsky R, Inbar O, Blank M Cohen J, Bakimer R, Shoenfeld Y (1993) In vitro effect of anticardiolipin autoantibodies upon total and pulsatile placental hCG secretion during early pregnancy. Am J Reprod Immunol 29:206–210
Di Somone N, Meroni PL, de Papa N, Raschi E, Caliandro D, De Carolis CS, Khamashta MA, Atsumi T, Hughes GR, Balestrieri G, Tincani A, Casali P, Caruso A (2000) Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein-I. Arthritis Rheum 43:140–150
Lyden T, Vogt E, Ng AK, Johnson PM, Rote NS (1992) Monoclonal antiphospholipid antibody reactivity against human placental trophoblast. J Reprod Immunol 22:1–14
Piona A, La Rosa L, Tincani A, Faden D, Magro G, Grasso S, Nicoletti F, Balestrieri G, Meroni PL (1995) Placental thrombosis and fetal loss after passive transfer of mouse lupus monoclonal or human polyclonal anti-cardiolipin antibodies in pregnant naive BALB/c mice. Scand J Immunol 41:427–432
Sugi T, Matsubayashi H, Inomo A, Dan L, Makino T (2004) Antiphosphatidylethanolamine antibodies in recurrent early pregnancy loss and mid-to-late pregnancy loss. J Obstet Gynaecol Res 30:326–332
McIntyre JA (2003) Antiphospholipid antibodies in implantation failures. Am J Reprod Immunol 49:221–229
Coulam CB (1999) The role of antiphospholipid antibodies in reproduction: questions answered and raised at the 18th Annual Meeting of the American Society of Reproductive Immunology. Am J Reprod Immunol 41:1–4
Rubio C, Rodrigo L, Perez-Cano I, Mercader A, Mateu E, Buendia P, Remohi J, Simon C, Pellicer A (2005) FISH screening of aneuploidies in preimplantation embryos to improve IVF outcome. Reprod Biomed Online 11:497–506
Bakimer R, Fishman P, Blank M, Sredni B, Djaldetti M, Shoenfeld Y (1992) Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3). J Clin Invest 89:1558–1563
Sher G, Fisch JD, Maassarani G, Matzner W, Ching W, Chong P (2000) Antibodies to phosphatidylethanolamine and phosphatidylserine are associated with increased natural killer cell activity in non-male factor infertility patients. Hum Reprod 15:1932–1936
Kaider AS, Kaider BD, Janowicz PB, Roussev RG (1999) Immunodiagnostic evaluation in women with reproductive failure. Am J Reprod Immunol 42:335–346
Mardesic T, Ulcova-Gallova Z, Huttelova R, Muller P, Voboril J, Mikova M, Hulvert J (2000) The influence of different types of antibodies on in vitro fertilization results. Am J Reprod Immunol 43:1–5
Eldar-Geva T, Wood C, Lolatgis N, Rombauts L, Kovacs G, Fuscaldo J, Trounson AO (1999) Cumulative pregnancy and live birth rates in women with antiphospholipid antibodies undergoing assisted reproduction. Hum Reprod 14:1461–1466
Egbase PE, Al Sharhan M, Diejomaoh M, Grudzinskas JG (1999) Antiphospholipid antibodies in infertile couples with two consecutive miscarriages after in-vitro fertilization and embryo transfer. Hum Reprod 14:1483–1486
American Society for Reproductive Medicine (1999) A Practice Committee report. Antiphospholipid antibodies do not affect IVF success. American Society for Reproductive Medicine, Birmingham, AL, USA, pp 1–3
Hornstein MD, Davis OK, Massey JB, Paulson RJ, Collins JA (2000) Antiphospholipid antibodies and in vitro fertilization success: a meta-analysis. Fertil Steril 73:330–333
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Carp, H.J.A., Shoenfeld, Y. Anti-Phospholipid Antibodies And Infertility. Clinic Rev Allerg Immunol 32, 159–161 (2007). https://doi.org/10.1007/s12016-007-0010-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12016-007-0010-2